About the STAR Trial
What is the Study of Trauma and Recovery (STAR) trial?
The STAR trial was the largest randomised controlled trial to date evaluating a trauma-focused therapy for people with psychosis and PTSD.
Funded by the National Institute for Health and Care Research (NIHR).
Led by researchers at King’s College London and South London and Maudsley NHS Foundation Trust.
RESEARCH QUESTIONS
What we wanted to find out
Primary research question
Does TF-CBTp reduce PTSD symptoms by the end of therapy in people experiencing psychosis and PTSD symptoms?
Secondary research questions
Does TF-CBTp reduce psychosis symptoms, distress and functioning problems?
Is this therapy acceptable to participants and to therapists?
Do the effects last?
Is it cost effective?
What did the STAR trial involve?
Who took part?
305 adults who met diagnostic criteria for PSTD and were experiencing distressing symptoms of psychosis.
What was involved?
Participants were randomly allocated to receive either
Trauma-Focused Cognitive Behaviour Therapy for psychosis plus usual care
or usual care alone
Therapy lasted around nine months with a trained therapist
Measures of PTSD, psychosis, emotional wellbeing, recovery, functioning, quality of life and acceptability were taken at the start and repeated at 4, 9 and 24 months.
Protocol, registration & analysis plans
TRIAL DOCUMENTS
STAR was registered prospectively, and its protocol and pre-specified analysis plans are published in full
STAR published protocol Multi-site randomised controlled trial of trauma-focused cognitive behaviour therapy for psychosis to reduce post-traumatic stress symptoms in people with co-morbid post-traumatic stress disorder and psychosis, compared to treatment as usual: study protocol for the STAR (Study of Trauma And Recovery) trial. Peters E, Hardy A, Dudley R et al., (2022). Trials Read more
STAR Trial Protocol Read more
STAR Statistical Analysis Plan (SAP) Read more
STAR Health Economics Analysis Plan (HEAP) Read more
STAR Serious Adverse Events form (version 7) Read more

